| Literature DB >> 26314534 |
Laurence S Sperling1, Jeffrey I Mechanick2, Ian J Neeland3, Cynthia J Herrick4, Jean-Pierre Després5, Chiadi E Ndumele6, Krishnaswami Vijayaraghavan7, Yehuda Handelsman8, Gary A Puckrein9, Maria Rosario G Araneta10, Quie K Blum11, Karen K Collins12, Stephen Cook13, Nikhil V Dhurandhar14, Dave L Dixon15, Brent M Egan16, Daphne P Ferdinand17, Lawrence M Herman18, Scott E Hessen19, Terry A Jacobson20, Russell R Pate21, Robert E Ratner22, Eliot A Brinton23, Alan D Forker24, Laura L Ritzenthaler25, Scott M Grundy26.
Abstract
The Cardiometabolic Think Tank was convened on June 20, 2014, in Washington, DC, as a "call to action" activity focused on defining new patient care models and approaches to address contemporary issues of cardiometabolic risk and disease. Individual experts representing >20 professional organizations participated in this roundtable discussion. The Think Tank consensus was that the metabolic syndrome (MetS) is a complex pathophysiological state comprised of a cluster of clinically measured and typically unmeasured risk factors, is progressive in its course, and is associated with serious and extensive comorbidity, but tends to be clinically under-recognized. The ideal patient care model for MetS must accurately identify those at risk before MetS develops and must recognize subtypes and stages of MetS to more effectively direct prevention and therapies. This new MetS care model introduces both affirmed and emerging concepts that will require consensus development, validation, and optimization in the future.Entities:
Keywords: cardiometabolic; cardiovascular disease; insulin resistance; obesity
Mesh：
Year: 2015 PMID： 26314534 DOI： 10.1016/j.jacc.2015.06.1328
Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094